Dr. André Gerth
Dr. André Gerth (CEO)
Chief Executive Officer (CEO) of Vita 34 AG
Born in 1964, 2 children
Responsible for strategy, production, research and development
Dr. André Gerth was appointed to the management board in June 2012 and appointed CEO on July 16, 2012.
Since 1991, he has been managing partner in several companies, among others CEO of BioPlanta GmbH, which he founded in 1992, until it was taken over by and merged with Vita 34.
Dr. André Gerth has many years of experience in the fields of biotechnology and project management and a broad international network of contacts. His company was awarded the Innovationspreis Mitteldeutschland in 2009 for developing a bioreactor technology for industrial production on the basis of plant stem cells.
Dr. Wolfgang Knirsch
Dr. Wolfgang Knirsch (CMO)
Chief Sales Officer (CMO) of Vita 34 AG
Born in 1960, 2 children
Dr. Wolfgang Knirsch was appointed CMO of Vita 34 in June 2016.
Dr. Wolfgang Knirsch received his PhD in inorganic chemistry by RWTH Aachen in 1993 and started his career in the pharmaceutical industry. He managed various national sales and marketing organizations with Aventis and Merck KGaA successfully. Between 2006 and 2015, Dr. Wolfgang Knirsch organized the operational and strategic marketing of Biotest AG. In his last position, he was responsible for international sales and increased revenues and results of cooperation partners worldwide in his sector in the long-term by consistently implementing the marketing and sales strategies.
Besides other therapeutic areas, he commands comprehensive knowledge in the fields of hemato-oncology, gynecology, and obstetrics.
Falk Neukirch (CFO)
Chief Financial Officer (CFO) of Vita 34 AG
Born in 1971, 2 children
Falk Neukirch was appointed CFO of Vita 34 in October 2015.
He graduated in business management from TU Dresden. Afterwards, he worked for a major auditing company for several years and then assumed various executive functions in the finance sector. From 2007 to 2014, Mister Neukirch worked as Director Controlling at the quoted First Sensor AG and successfully conducted several business acquisitions during this time. Between 2014 and October 2015, Mister Neukirch worked as Financial Director with general commercial power of representation at BGH Edelstahlwerke GmbH.
Falk Neukirch commands comprehensive knowledge in the international financial reporting standards (IFRS) required for quoted companies as well as experience in the acquisition and integration of businesses.
Following the resolution on the amendment of the articles of association to extend the supervisory board, three new members were elected to the supervisory board at the general meeting July 28, 2015. The new members of the supervisory board are Mister Artur Isaev, Mister Heinrich Sundermeyer, and Mrs. Gerrit Witschaß. Furthermore, Dr. med. Mariola Söhngen was elected the replacement member.
At the meeting on July 28, 2015, the supervisory board elected the member of the supervisory board Mister Alexander Starke the new vice chairman of the supervisory board. He took over the position from Dr. Holger Födisch the same day, who remains a member of the supervisory board. Chairman of the supervisory board is and remains Dr. Hans-Georg Giering.
With effect from December 31, 2015, Mister Heinrich Sundermeyer resigned from the supervisory board for health reasons. Dr. Mariola Söhngen takes over his position with effect from January 1, 2016.